A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma
A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma
复制标题
肝细胞癌术后过继性免疫治疗的荟萃分析
DOI：
10.4103/jcrt.jcrt_858_17
复制
发表时间：
2018-10
影响因子：
1.3
通讯作者：
Wu Tao
中科院分区：
文献类型：
--
作者：
Zhao Hui;Zheng Min;Wang Kun;Wang Lianmin;He Haiyu;Wang Meilian;Shi Yanmei;Huang Songquan;Ji Fengming;Li Xiao;Zhu Hong;Wang Lin;Zhang Xiaowen;Shi Xueyang;Zhao Songling;Fu Bimang;Wu Tao
背景：过继免疫治疗（AIT）已被用作肝细胞癌（HCC）患者根治治疗后的辅助治疗。然而，美国在台协会的结果仍有争议。目的：本研究的目的是分析
Background: Adoptive immunotherapy (AIT) has been adopted as an adjuvant treatment for hepatocellular carcinoma (HCC) patients after curative therapy. However, the outcomes of AIT remain controversial. Purpose: The purpose of this study is to analyze the